EUVIMEDEUVIMED entdecken
KommentarOpen Access · CC BY 4.0

Identification of HRH1 as an alternative receptor for SARS-CoV-2: insights from viral inhibition by repurposable antihistamines

Gang Zhong, Jinrong Li, Huiqing Wang iD

mBio · 2024

DOI: 10.1128/mbio.01697-24 ↗

Kurz gefasst

Kommentar in der Zeitschrift mBio, 2024. Verfasst von Gang Zhong und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedic Surgery, West China Hospital, Sichuan University, Chengdu, China. Hauptthemen laut MEDLINE: SARS-CoV-2, Drug Repositioning, Virus Internalization. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Technology Department of Sichuan Province (SPDST), MOST | National Key Research and Development Program of China (NKPs), Sichuan University's "0 to 1" innovation research program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Numerous coreceptors have been shown to facilitate hACE2-dependent or hACE2-independent infection by SARS-CoV-2. A recent study published in mBio by Yu et al. showed that the histamine receptor H1 (HRH1) functions as an alternative receptor for SARS-CoV-2 via direct binding to viral spike proteins (F. Yu, X. Liu, H. Ou, X. Li, et al., mBio e01088-24, 2024, https://doi.org/10.1128/mbio.01088-24 ). Furthermore, they present compelling evidence that antihistamine drugs targeting HRH1 potently inhibit SARS-CoV-2 entry. This study highlights the therapeutic potential of repurposable antihistamines against COVID-19.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2Drug RepositioningVirus InternalizationHumansCOVID-19 Drug TreatmentHistamine AntagonistsSpike Glycoprotein, CoronavirusAntiviral AgentsReceptors, Histamine H1COVID-19Receptors, Virus

Stichwörter der Autor:innen

HRH1SARS-CoV-2receptorviral entry

Substanzen

Histamine AntagonistsSpike Glycoprotein, CoronavirusAntiviral AgentsReceptors, Histamine H1spike protein, SARS-CoV-2Receptors, Virus

Autor:innen und Institutionen

  • Department of Orthopedic Surgery, West China Hospital, Sichuan University, Chengdu, China.
  • Trauma Center, West China Hospital, Sichuan University, Chengdu, China.
  • Department of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu, China.
  • Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu, China.

ORCID-Profile: Huiqing Wang

Förderung

  • Science and Technology Department of Sichuan Province (SPDST)
  • MOST | National Key Research and Development Program of China (NKPs)
  • Sichuan University's "0 to 1" innovation research program

Zitieren

APA

Zhong, G., Li, J., & Wang, H. (2024). Identification of HRH1 as an alternative receptor for SARS-CoV-2: insights from viral inhibition by repurposable antihistamines. mBio. https://doi.org/10.1128/mbio.01697-24

Vancouver

Zhong G, Li J, Wang H. Identification of HRH1 as an alternative receptor for SARS-CoV-2: insights from viral inhibition by repurposable antihistamines. mBio. 2024. doi:10.1128/mbio.01697-24

BibTeX
@article{Zhong2024,
  author = {Zhong, Gang and Li, Jinrong and Wang, Huiqing},
  title = {Identification of HRH1 as an alternative receptor for SARS-CoV-2: insights from viral inhibition by repurposable antihistamines},
  journal = {mBio},
  year = {2024},
  doi = {10.1128/mbio.01697-24}
}
Kostenlos starten →